Lung Cancer News and Research

Latest Lung Cancer News and Research

Molecule called DJ-1 is likely to be involved in the generation of human tumors

Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.

14 Mar 2005

Association between prolonged residential radon exposure and lung cancer risk

Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.

14 Mar 2005

Finding may open new horizons for understanding the initiation of chemically induced cancers

A team from the chemistry and biology departments of New York University, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), has uncovered a conformational switch - a change in shape in a carcinogen-damaged DNA site - in tumor suppressor genes altered by a known cancer-causing chemical found in cigarette smoke.

9 Mar 2005

Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients

Using Positron Emission Tomography in addition to Computed Tomography can reduce the amount of radiation exposure to normal tissue in some lung cancer patients

8 Mar 2005

Lung cancer rates among men are on the decline

Results of the most comprehensive analysis to date of the impact of gender differences in lung cancer incidence in the United States indicate that lung cancer rates among men are on the decline, while the rate in women remains steady.

8 Mar 2005

Underhand methods used to challenge secondhand smoke's link to infant death risk

The link between secondhand smoke and sudden infant death has been discredited in the last few years in scientific articles paid for and influenced by cigarette manufacturers, according to a new study of once-secret industry documents.

7 Mar 2005

ViroLogic and AstraZeneca to conduct Iressa biomarker study

ViroLogic announced today that it had entered into an agreement with AstraZeneca to conduct a cancer biomarker study with application to Iressa, AstraZeneca's selective epidermal growth factor receptor kinase inhibitor.

7 Mar 2005

Important advance in our understanding of colorectal cancer

An international team of medical scientists has made an important advance in our understanding of the second most fatal form of cancer in the industrialized world. Professor Jeremy R. Jass, who holds a Canada Research Chair in Gastrointestinal Pathology at McGill University in Montreal

3 Mar 2005

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Dr.Adi Gazdar, professor of pathology in the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and senior author of the study in today's issue of the Journal of the National Cancer Institute, explains that the findings may show why certain lung cancer patients respond dramatically to a specific form of targeted therapy while others have little or no response.

2 Mar 2005

Molecule from South American tree Quillaja, helps battle disease

The first synthesis of QS-21A, a medicinally important molecule that helps the body battle disease, has been achieved by chemists at the University of Illinois at Urbana-Champaign.

1 Mar 2005

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Lung cancer patients who have never smoked are more likely than smokers to harbor one of two genetic mutations that researchers at UT Southwestern Medical Center have now linked to the disease.

1 Mar 2005

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.

27 Feb 2005

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).

22 Feb 2005

Deaths from mesothelioma will peak within ten years in the UK

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer.

17 Feb 2005

$9.8 million grant to research cancer risks from space radiation

NASA awarded a research grant worth more than $9.8 million over five-years to the University of Texas Southwestern Medical Center in Dallas.

16 Feb 2005

Blocking estrogen may be vitally important to improving survival from lung cancer

New and effective treatments for lung cancer may rest on their ability to hinder the action of estrogen in lung cancer cells, according to two studies published in the current issue of Cancer Research.

15 Feb 2005

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.

10 Feb 2005

Lung Cancer News and Research

Latest Lung Cancer News and Research

Molecule called DJ-1 is likely to be involved in the generation of human tumors

Association between prolonged residential radon exposure and lung cancer risk

Finding may open new horizons for understanding the initiation of chemically induced cancers

Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients

Lung cancer rates among men are on the decline

Underhand methods used to challenge secondhand smoke's link to infant death risk

ViroLogic and AstraZeneca to conduct Iressa biomarker study

Important advance in our understanding of colorectal cancer

Researchers identify first known mutation to occur in lung cancer patients who have never smoked

Molecule from South American tree Quillaja, helps battle disease

Study describes the first known mutation to occur in lung cancer patients who have never smoked

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Deaths from mesothelioma will peak within ten years in the UK

$9.8 million grant to research cancer risks from space radiation

Blocking estrogen may be vitally important to improving survival from lung cancer

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Patients with cancer have a 7-fold increased risk for blood clots in the legs or lungs

Smoke free laws protect health and save lives worldwide

Eleventh Edition of the Report on Carcinogens

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in